| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 49.7671 | 48 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.6673 | 40 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.861 | 36 |
| GSM780719 | Untreated after 4 days (C1_2) | 49.4007 | 46 |
| GSM780720 | Untreated after 4 days (C2_2) | 49.6114 | 47 |
| GSM780721 | Untreated after 4 days (C3_2) | 47.8913 | 41 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 48.0415 | 41 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 50.6869 | 51 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 52.0236 | 54 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 45.7676 | 31 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 48.7871 | 44 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 57.8449 | 63 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 53.0989 | 56 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 60.8353 | 65 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 54.2707 | 58 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 45.2719 | 28 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.8409 | 26 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 53.3595 | 57 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.9158 | 32 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 53.6502 | 57 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 53.5831 | 57 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 49.4 | 46 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 52.2789 | 55 |